ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 69 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18 | -99.8% | 34,141 | +134.6% | 0.00% | – |
| Q3 2022 | $11,000 | -45.0% | 14,553 | -18.8% | 0.00% | – |
| Q2 2022 | $20,000 | -60.8% | 17,929 | -27.5% | 0.00% | -100.0% |
| Q1 2022 | $51,000 | -62.8% | 24,725 | -48.1% | 0.00% | 0.0% |
| Q4 2021 | $137,000 | +38.4% | 47,659 | +103.1% | 0.00% | 0.0% |
| Q3 2021 | $99,000 | -57.7% | 23,466 | -46.8% | 0.00% | -66.7% |
| Q2 2021 | $234,000 | +178.6% | 44,147 | +144.6% | 0.00% | +200.0% |
| Q1 2021 | $84,000 | -85.0% | 18,047 | -89.1% | 0.00% | -93.3% |
| Q2 2020 | $559,000 | +598.8% | 165,731 | +1147.0% | 0.02% | +650.0% |
| Q4 2019 | $80,000 | – | 13,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |